OMER - Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript
2024-04-01 20:09:09 ET
Omeros Corporation (OMER)
Q4 2023 Earnings Conference Call
April 01, 2024, 4:30 PM ET
Company Participants
Peter Cancelmo - Investor Relations
Gregory Demopulos - Chairman and Chief Executive Officer
Michael Jacobsen - Chief Accounting Officer
Steven Whitaker - Vice President, Clinical Development
Catherine Melfi - Chief Regulatory Officer
Nadia Dac - Chief Commercial Officer
Andreas Grauer - Chief Medical Officer
Conference Call Participants
Olivia Brayer - Cantor Fitzgerald
Stephen Brozak - WBB Securities
Serge Belanger - Needham
Presentation
Operator
Good afternoon and welcome to today's conference call from Omeros Corporation. At this time, all participants are in a listen-only mode. After the company's remarks, we will conduct a question-and-answer session. Please be advised that today's call is being recorded at the company's request and a replay will be available on the company's website for one week from today.
I'll turn the call over to Peter Cancelmo, General Counsel of Omeros. You can begin.
Peter Cancelmo
Good afternoon and thanks for joining the call today. I'd like to remind you that some of the statements that will be made on the call today will be forward-looking. These statements are based on management's beliefs and expectations as of today only and are subject to change.
All forward-looking statements involve risks and uncertainties that could cause the company's actual results to differ materially. Please refer to the Risk Factor section of the company's annual report on Form 10-K, which was filed with the SEC today for a discussion of these risks and uncertainties.
Now I would like to turn the call over to Dr. Greg Demopulos, Omeros' Chairman and CEO.
Gregory Demopulos
All right. Thank you, Peter, and good afternoon, everyone. I'm joined on today's call by our Chief Accounting Officer, Mike Jacobson; and our Chief Commercial Officer; Nadia Dac; our Chief Medical Officer, Andreas Grauer; our Chief Regulatory Officer, Cathy Melfi; and our Clinical Vice President, Steve Whitaker....
Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript